Post

Signal: Illumina may be on its way to divest Grail, but legal trouble looms

Diagnostics giant Illumina could seek an outright sale of Grail, a cancer detection test manufacturer. In an interview on 28 November …

BlueSkeye AI to begin trial of AI mental health app for perinatal depression

The Medical and Healthcare products Regulatory Agency (MHRA) has greenlit BlueSkeye AI to begin a clinical trial investigating its TrueBlue …

Johnson & Johnson MedTech acquires heart implant company Laminar for $400m

Johnson & Johnson (J&J) MedTech has made an upfront payment of $400m to acquire the privately held company Laminar, a …

Empatica launches clinical trial to predict refractory seizures with AI

Wearable tech firm Empatica has announced it is developing a clinical trial intent on using artificial intelligence (AI) and wearable …

Proximie announce blueprint to digitalise operating rooms at Slush 

Proximie has launched its software development kit (SDK), which is focused on digitising operating and diagnostic rooms.  The healthcare platform combines …